A gene named transmembrane serine protease 2 (TMPRSS2) for which alteration was historically associated with prostate tumorigenesis was recently confirmed to be involved in facilitating the SARS-CoV-2 entry into host cells. This evidence concerns the gene TMPRSS2 and medical procedure.